Multiple alterations to a class of fat (lipid) molecules called glycosphingolipids (GSLs) are observed in the blood of people with Parkinson’s disease compared with those without the disease, according to a recent study. These changes, some of which are linked to Parkinson’s symptoms such as motor and cognitive…
News
Among people with Parkinson’s disease, those with the skin disease psoriasis tend to experience slightly faster disease progression, according to a new analysis of genetic data. “These findings provided a better understanding of the role of psoriasis in the pathogenesis [disease development] of [Parkinson’s], and had clinical implications for…
Women with Parkinson’s disease experience more and worse pain than men with the neurodegenerative condition, according to a new study that highlights sex differences in the prevalence and severity of these symptoms. Chronic pain, pain related to motor symptom fluctuations, mouth/face (oro-facial) pain, and discoloration/swelling were all more prevalent…
The University of Arkansas for Medical Sciences (UAMS Health) has been designated a Comprehensive Care Center by the Parkinson’s Foundation Global Care Network, in an acknowledgement of the care it provides its Parkinson’s disease (PD) patients. The designation goes to medical facilities that have specialized teams that provide evidence-based…
Exposure to aluminum increased the activity of several genes related to Parkinson’s disease in zebrafish, a new study shows. While these data do not necessarily demonstrate a link between aluminum exposure and Parkinson’s development, they shed further light on the neurotoxic properties of aluminum, researchers said. The study, “…
Parkinson’s disease (PD) patients in 42 states stand to benefit from $2 million in community grants the Parkinson’s Foundation has distributed this year to support a variety of health, wellness, and educational programs. “Investing in community-based organizations allows the foundation to direct resources to meaningful PD programs and…
Parkinson’s disease patients who have mild cognitive impairment tend to have lower levels of certain bile acids — substances made in the liver that are used to help digest fats — than patients with normal cognition, according to a new study. The study, “Distinct Bile Acid…
Day Three Labs, known as DTL, is launching an initiative to develop “consistent, reliable and repeatable” cannabis-based therapies for people with Parkinson’s disease. The work will be funded by CanNegev, a cannabis innovation incubator sponsored by the government of Israel. “Parkinson’s Disease and…
Kyowa Kirin has discontinued the clinical development of its investigational treatment, KW-6356, for Parkinson’s disease, despite Phase 2 clinical trial data showing promising results as a monotherapy or in combination with levodopa. The decision was based on the “global regulatory landscape, development hurdles, and timelines for potential market…
Among pairs of genetically identical twins, one with Parkinson’s disease and the other twin without it, minimal variation is evident in the makeup of bacteria living in the digestive tract, according to a new study. This finding highlights the role of person-to-person variability in influencing the gut microbiome, which researchers…
Recent Posts
- How being a skilled queen bee prepared me for Parkinson’s caregiving
- Grants fund tests of portable devices in Parkinson’s speech therapy
- Light therapy device seen to brighten life quality for those with Parkinson’s
- When early memories of Parkinson’s came full circle
- FDA grants advanced therapy status to Parkinson’s cell treatment